Time course of changes in the level of N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with rheumatoid arthritis during therapy with an interleukin-6 receptor inhibitor

Objective: to investigate the impact of therapy with the interleukin-6 receptor inhibitor tocilizumab (TCZ) on the time course of changes in N-terminal pro-brain  natriuretic  peptide (NT-proBNP) levels in patients with rheumatoid arthritis (RA) during a 12-month follow-up period.Subjects and method...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: E. V. Gerasimova, T. V. Popkova, A. V. Martynova, M. V. Cherkasova, D. S. Novikova
Formatua: Artigo
Hizkuntza:Russo
Argitaratua: IMA-PRESS LLC 2019-11-01
Saila:Научно-практическая ревматология
Gaiak:
nt-probnp
rheumatoid arthritis
chronic heart failure
tocilizumab
Sarrera elektronikoa:https://rsp.mediar-press.net/rsp/article/view/2783
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak